Suppr超能文献

磷酸盐毒性的特征在血磷酸盐正常时会出现吗?

Can features of phosphate toxicity appear in normophosphatemia?

机构信息

Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Room: 304, 188 Longwood Avenue, Boston, MA 02115, USA.

出版信息

J Bone Miner Metab. 2012 Jan;30(1):10-8. doi: 10.1007/s00774-011-0343-z. Epub 2012 Jan 5.

Abstract

Phosphate is an indispensable nutrient for the formation of nucleic acids and the cell membrane. Adequate phosphate balance is a prerequisite for basic cellular functions ranging from energy metabolism to cell signaling. More than 85% of body phosphate is present in the bones and teeth. The remaining phosphate is distributed in various soft tissues, including skeletal muscle. A tiny amount, around 1% of total body phosphate, is distributed both in the extracellular fluids and within the cells. Impaired phosphate balance can affect the functionality of almost all human systems, including muscular, skeletal, and vascular systems, leading to an increase in morbidity and mortality of the involved patients. Currently, measuring serum phosphate level is the gold standard to estimate the overall phosphate status of the body. Despite the biological and clinical significance of maintaining delicate phosphate balance, serum levels do not always reflect the amount of phosphate uptake and its distribution. This article briefly discusses the potential that some of the early consequences of phosphate toxicity might not be evident from serum phosphate levels.

摘要

磷酸盐是核酸和细胞膜形成所必需的营养物质。适当的磷酸盐平衡是从能量代谢到细胞信号传导等基本细胞功能的前提。超过 85%的体内磷酸盐存在于骨骼和牙齿中。其余的磷酸盐分布在各种软组织中,包括骨骼肌。一小部分,约占总磷酸盐的 1%,分布在细胞外液和细胞内。磷酸盐平衡受损会影响几乎所有人体系统的功能,包括肌肉、骨骼和血管系统,从而增加受累患者的发病率和死亡率。目前,测量血清磷酸盐水平是评估全身磷酸盐状况的金标准。尽管维持精细磷酸盐平衡具有生物学和临床意义,但血清水平并不总是反映磷酸盐的摄取量及其分布。本文简要讨论了一些磷酸盐毒性的早期后果可能不会从血清磷酸盐水平中明显表现出来的可能性。

相似文献

1
Can features of phosphate toxicity appear in normophosphatemia?
J Bone Miner Metab. 2012 Jan;30(1):10-8. doi: 10.1007/s00774-011-0343-z. Epub 2012 Jan 5.
2
Phosphate toxicity: new insights into an old problem.
Clin Sci (Lond). 2011 Feb;120(3):91-7. doi: 10.1042/CS20100377.
3
Extracellular Phosphate, Inflammation and Cytotoxicity.
Adv Exp Med Biol. 2022;1362:15-25. doi: 10.1007/978-3-030-91623-7_3.
4
Bone-kidney axis in systemic phosphate turnover.
Arch Biochem Biophys. 2014 Nov 1;561:154-8. doi: 10.1016/j.abb.2014.06.031. Epub 2014 Jul 2.
5
Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
Kidney Int. 2014 May;85(5):1103-11. doi: 10.1038/ki.2013.332. Epub 2013 Oct 2.
6
Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging.
FASEB J. 2010 Sep;24(9):3562-71. doi: 10.1096/fj.09-152488. Epub 2010 Apr 23.
7
Osteo-renal regulation of systemic phosphate metabolism.
IUBMB Life. 2011 Apr;63(4):240-7. doi: 10.1002/iub.437. Epub 2011 Mar 24.
8
The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.
Nat Rev Endocrinol. 2009 Nov;5(11):611-9. doi: 10.1038/nrendo.2009.196.
9
Phosphate Metabolism in Health and Disease.
Calcif Tissue Int. 2021 Jan;108(1):3-15. doi: 10.1007/s00223-020-00686-3. Epub 2020 Apr 7.
10
Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system.
Adv Chronic Kidney Dis. 2011 Mar;18(2):91-7. doi: 10.1053/j.ackd.2010.11.007.

引用本文的文献

3
Can a Low-Phosphate Diet for Chronic Kidney Disease Treat Cancer? An Interdisciplinary Literature Review.
Medicines (Basel). 2024 Jan 30;11(2):5. doi: 10.3390/medicines11020005.
5
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.
Medicina (Kaunas). 2023 May 16;59(5):959. doi: 10.3390/medicina59050959.
6
Phosphate Dysregulation and Metabolic Syndrome.
Nutrients. 2022 Oct 25;14(21):4477. doi: 10.3390/nu14214477.
7
Parkinson's Disease Etiology: Insights and Associations with Phosphate Toxicity.
Int J Mol Sci. 2022 Jul 22;23(15):8060. doi: 10.3390/ijms23158060.
8
Phosphate and Cellular Senescence.
Adv Exp Med Biol. 2022;1362:55-72. doi: 10.1007/978-3-030-91623-7_7.
9
Vitamin D and Phosphate Interactions in Health and Disease.
Adv Exp Med Biol. 2022;1362:37-46. doi: 10.1007/978-3-030-91623-7_5.
10
Phosphate Burden and Inflammation.
Adv Exp Med Biol. 2022;1362:7-13. doi: 10.1007/978-3-030-91623-7_2.

本文引用的文献

1
Evaluation of hypophosphatemia: lessons from patients with genetic disorders.
Am J Kidney Dis. 2012 Jan;59(1):152-9. doi: 10.1053/j.ajkd.2011.08.035. Epub 2011 Nov 9.
2
Rabbit model of primary hyperparathyroidism induced by high-phosphate diet.
Domest Anim Endocrinol. 2012 Jan;42(1):20-30. doi: 10.1016/j.domaniend.2011.09.001. Epub 2011 Oct 3.
3
Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice.
Biochem Biophys Res Commun. 2011 Nov 25;415(3):434-8. doi: 10.1016/j.bbrc.2011.10.076. Epub 2011 Oct 20.
4
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
J Bone Miner Metab. 2012 Jan;30(1):93-9. doi: 10.1007/s00774-011-0290-8. Epub 2011 Jul 8.
5
FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
J Bone Miner Metab. 2012 Jan;30(1):78-84. doi: 10.1007/s00774-011-0285-5. Epub 2011 Jun 28.
7
Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells.
Acta Histochem Cytochem. 2011 Apr 28;44(2):35-41. doi: 10.1267/ahc.11001. Epub 2011 Apr 21.
8
Osteo-renal regulation of systemic phosphate metabolism.
IUBMB Life. 2011 Apr;63(4):240-7. doi: 10.1002/iub.437. Epub 2011 Mar 24.
9
Phosphate and FGF-23.
Kidney Int Suppl. 2011 Apr;79(121):S24-7. doi: 10.1038/ki.2011.27. Epub 2011 Feb 23.
10
Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta.
J Bone Miner Metab. 2011 Sep;29(5):598-605. doi: 10.1007/s00774-011-0262-z. Epub 2011 Feb 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验